Keller, Karsten
Hobohm, Lukas
Barco, Stefano
Schmidtmann, Irene
Münzel, Thomas
Engelhardt, Martin
Eckhard, Lukas
Konstantinides, Stavros V.
Drees, Philipp
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (BMBF 01EO1503, BMBF 01EO1503, BMBF 01EO1503, BMBF 01EO1503, BMBF 01EO1503, BMBF 01EO1503)
Projekt DEAL
Article History
Received: 28 February 2020
Accepted: 4 December 2020
First Online: 31 December 2020
Competing interests
: The authors report no proprietary or commercial interest in any product mentioned or concept discussed in this article. KK, IS, TM, ME, LE and PD report no conflict of interest. LH reports having received lecture honoraria from MSD. TM is PI of the DZHK (German Center for Cardiovascular Research), Partner Site Rhine-Main, Mainz, Germany. SB received lecture or consultant fees from Bayer HealthCare, BTG Pharmaceuticals, and LeoPharma and economical support for travel or congress costs from Daiichi Sankyo and Bayer HealthCare, outside of the submitted work. SK reports having received consultancy and lecture honoraria from Bayer, Boehringer Ingelheim, Daiichi-Sankyo, MSD and Pfizer-Bristol-Myers Squibb; and institutional grants from Actelion, Bayer, Boehringer Ingelheim, Daiichi-Sankyo and Pfizer-Bristol-Myers Squibb. The employment as well as the commercial support—mentioned above—had no impact on conceptualization, design, data collection, analysis, decision to publish, or preparation of the manuscript.